American Society of Hirudotherapy

Leech Antistasin-Homolog Anticoagulant

Novel Hirudo medicinalis salivary protein (28% identity to antistasin) with stronger aPTT inhibition than hirudin at equimolar concentration — Manuvera 2024.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 27, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Leech Antistasin-Homolog Anticoagulant15 kDa
Molecular weight (kilodaltons) of Leech Antistasin-Homolog Anticoagulant (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Recombinant (genetically expressed)
Safety domains
Bleeding

Clinical translation limit

This new protein's in vitro aPTT activity at equimolar superior to hirudin does NOT establish clinical efficacy. No FDA-approved derivative exists; mechanistic discrepancy between clotting-positive and chromogenic-negative FXa assays requires further investigation.

Molecular Profile

Category
Anticoagulant
Evidence tier
Preclinical
Molecular weight
15,000 Da
Source species
Hirudo medicinalis
Discovered
2024 · Manuvera VA et al.

Biological Targets

  • → thrombin (direct, weaker than hirudin)
  • → factor Xa-related clotting (clotting-assay positive, chromogenic-negative)

Key Citations

  1. Manuvera VA et al. (2024), Biochem Biophys Res Commun · PMID 38241814

External Resources

    Related Anticoagulant Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.